Peiwu Geng
Papers
1
Total Citations
15
H-Index
1
About
Dr. Peiwu Geng is a leading researcher at the forefront of cancer nanomedicine, whose work charts the evolution of precision oncology from foundational principles to next-generation therapeutics. His major contributions center on advancing smart targeting strategies, moving beyond passive EPR-mediated accumulation to develop active ligand-directed and stimuli-responsive drug delivery systems. Dr. Geng’s highly cited 2025 review, “Recent advances in cancer nanomedicine,” with 15 citations, provides a comprehensive roadmap of the field’s progression since the 1995 approval of Doxil®, establishing him as a key voice in personalized cancer treatment. His research systematically addresses critical challenges in tumor targeting, drug release kinetics, and therapeutic efficacy, bridging laboratory innovations with clinical translation. By synthesizing decades of progress into actionable frameworks, Dr. Geng’s work empowers researchers and clinicians to design more effective, patient-specific nanomedicines. His contributions are shaping the next era of oncology, where programmable nanocarriers promise to transform cancer care through enhanced precision and reduced side effects.
Research Focus
Key Achievements
Top Papers
- 1